SENSEX NIFTY

Glaxosmithkline Pharmaceuticals Ltd

Oct 21, 2014 at 14:46 | Source: Moneycontrol.com
Suven Life Sciences Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on October 21, 2014.
Oct 21, 2014 at 13:58 | Source: Moneycontrol.com
Zyden Gentec Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 31, 2014 to consider, discuss and confirm the matter of Split of Shares of the Company.
Oct 21, 2014 at 13:41 | Source: Moneycontrol.com
Wanbury Ltd has informed BSE that union workers at the Company's Tanaku, Andhra Pradesh Plant has gone on strike affecting the production partially in that Plant. Management is making all efforts to get back the production to normal capacity.
Oct 21, 2014 at 11:00 | Source: Moneycontrol.com
Sanofi India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 11, 2014 for approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2014 (Q3).
Oct 21, 2014 at 10:38 | Source: Moneycontrol.com
Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 03, 2014, to consider and approve the unaudited financial results (consolidated and standalone) of the Company for the second quarter and half year ended September 30, 2014.
Oct 21, 2014 at 10:23 | Source: Moneycontrol.com
Bal Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 20, 2014, approved the issue and allotment of 13,00,000 warrants to the subscribers on preferential basis, at a conversion price of Rs.62/- per warrant.
Oct 20, 2014 at 15:02 | Source: Moneycontrol.com
Granules India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 20, 2014, has approved the setting up of 100% wholly owned subsidiary in USA.
Oct 20, 2014 at 15:01 | Source: Moneycontrol.com
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 28, 2014, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2014 (Q2).
Oct 20, 2014 at 12:14 | Source: Moneycontrol.com
Arvind Remedies Ltd has informed BSE that Mr. S Balakrishnan, Finance Controller of the Company, has resigned from the Services. The Company has joined Mr. Selven Danial as Chief Financial Officer and he has joined the Company from Oct 13, 2014.
Oct 20, 2014 at 11:34 | Source: Moneycontrol.com
Sharon Bio-Medicine Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on October 20, 2014 has resolved and allotted 1,61,11,000 Warrants to the Promoter group on Preferential basis in compliance of SEBI (Issue Of Capital And Disclosure Requirements) Regulations, 2009.
Messages on Glaxosmithkline Pharmaceuticals Ltd »

BSE/NSE Announcer

Platinum Member

4691 Followers

GlaxoSmithKline  

12.06 PM May 16th

BSE/NSE Announcer

Platinum Member

4691 Followers

GlaxoSmithKline  

12.18 PM Apr 17th

BSE/NSE Announcer

Platinum Member

4691 Followers

GlaxoSmithKline  

3.55 PM Mar 26th

BSE/NSE Announcer

Platinum Member

4691 Followers

GlaxoSmithKline  

2.00 PM Mar 25th

BSE/NSE Announcer

Platinum Member

4691 Followers

GlaxoSmithKline  

4.39 PM Mar 13th

vk1939

Platinum Member

166 Followers

GlaxoSmithKline  

7.08 PM Feb 18th

yrfriend007

Platinum Member

101 Followers

GlaxoSmithKline  

3.51 PM Feb 18th

BSE/NSE Announcer

Platinum Member

4691 Followers

GlaxoSmithKline  

2.00 PM Feb 18th

BSE/NSE Announcer

Platinum Member

4691 Followers

GlaxoSmithKline  

1.51 PM Feb 18th

kabiroberoi
90

New Member

0 Follower

GlaxoSmithKline  

1.04 PM Feb 18th

News across the web »
Feb 18, 2014 at 10:41 | Source: Economic Times
Feb 18, 2014 at 08:26 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.